Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 784.45

-0.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Miljenko Zuanic	3/15/2015 7:50:06 PM
	Read Replies (1) of 3559

Sanofi CONFIDENCE or STUPIDITY???? Based on observed event rate per year in "Long term safety" trial (~1.5 % for placebo and ~1.0% for drug) they decide not to change pts numbers, while AMGN and PFE INCREASED THEIR NUMBERS BY ALMOST 10K!!! Robustness of the data will dictate marketing success, so bigger is better in this case! Note: IF event rate accelerate in second and third year (as early data indicate), than +40% reduction SHOULD be observed at interim analysis (75% of event projected), and trial stopped early. What am I missing????

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next